When is an opioid safe to take?
(HealthDay)—Many people in pain are apprehensive about taking an opioid painkiller to ease their suffering, and rightfully so.
Jun 26, 2017
1
3
(HealthDay)—Many people in pain are apprehensive about taking an opioid painkiller to ease their suffering, and rightfully so.
Jun 26, 2017
1
3
Many Americans have been directly touched by the opioid crisis—more than a quarter of Americans and more than a third of millennials, report knowing someone who has been addicted to opioids or prescription painkillers. ...
May 23, 2017
1
2
U.S. regulators are strengthening warnings about the dangers of two types of powerful painkillers due to risks of slowed breathing and death.
Apr 21, 2017
0
0
The maker of the pain medication OxyContin has asked a federal judge in Seattle to throw out a Washington city's lawsuit that seeks to hold the drugmaker responsible for allowing its pills to flood the black market and into ...
Mar 21, 2017
1
0
People hooked on prescription painkillers were able to use a drug at home to curb cravings and prevent abuse while waiting to get in a treatment program, finds a small study that gives hope for a new way to fight the opioid ...
Dec 21, 2016
0
0
Drug overdose deaths have increased by 33 percent in the past five years across the country, with some states seeing jumps of nearly 200 percent.
Dec 16, 2016
0
16
(HealthDay)—Discussing the risk of long-term opioid use disorder with patients is associated with reduced misuse of opioids, according to research published in the November/December issue of the Annals of Family Medicine.
Nov 22, 2016
0
0
(HealthDay)—The U.S. Drug Enforcement Administration (DEA) says it has mandated significant cuts in the production of powerful prescription opioid painkillers.
Oct 6, 2016
0
0
Ohio doctors are supposed check patients' prescription histories against a state website before recommending prescription painkillers, but an audit has found that some 12,000 physicians appear to be violating the policy aimed ...
Sep 30, 2016
0
1
One of the companies alleged to have conspired to keep generic versions of a popular opioid treatment off the market says the antitrust lawsuit has no merit.
Sep 23, 2016
0
0